Applied Antibiotic Use & Antimicrobial Stewardship

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/20

flashcard set

Earn XP

Description and Tags

Vocabulary practice cards covering common veterinary antibiotics, empirical therapy, storage requirements, and antimicrobial stewardship principles based on lecture notes.

Last updated 10:24 AM on 6/13/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

21 Terms

1
New cards

Empirical Therapy

Therapy based on experience; a clinically-educated guess frequently justified when there is no access to microbiology or therapy is needed immediately.

2
New cards

Four Quadrant Therapy (Equine)

A combination typically consisting of an aminoglycoside and a (potentiated) beta-lactam, commonly referred to as "PenGent."

3
New cards

Four Quadrant Therapy (Small Animal)

A combination typically consisting of a fluoroquinolone and a (potentiated) beta-lactam, commonly referred to as "Baytril n' Clav."

4
New cards

Tilmicosin (Production Animal Precautions)

Indicated only for non-dairy cattle and must never be administered IVIV.

5
New cards

Oxytetracycline (IM Side Effects)

Oily preparations are irritating and can cause sterile abscessation following IMIM injection; use caution if near to slaughter.

6
New cards

Beta-Lactam Administration Rule

These should be kept refrigerated, and as a rule, "nothing white goes into a vein."

7
New cards

Fluoroquinolones (Australian Regulation)

Subject to a nationwide ban in all Australian food-producing species, including cattle.

8
New cards

Aminoglycoside Injectables (Australian Regulation)

Prohibited in food-producing species, as the APVMA has flagged deregistration for products where systemic absorption occurs.

9
New cards

Metronidazole

Commonly used in veterinary medicine for pets and horses but should not be used in production animals.

10
New cards

Limitations of In Vitro Susceptibility Testing

It is a predictor of in vivo success and should guide rather than dictate therapy, as it uses monomorphic populations growing logarithmically under specific laboratory conditions.

11
New cards

Biofilms

Protective layers produced by bacteria like Staph. aureus and Pseudomonas aeruginosa that many antibiotics cannot penetrate, though fluoroquinolones can.

12
New cards

Antibiotic Storage (Light Protection)

Drugs in brown bottles must be protected from light and should not be aliquoted into clear syringes for owners.

13
New cards

Antibiotic Storage (Moisture Protection)

Drugs individually wrapped in foil must be protected from moisture and sometimes light.

14
New cards

Antibiotic Resistance Origin

Arises from spontaneous mutations in bacterial DNA; antibiotics do not cause resistance but select for it, leading to proliferation.

15
New cards

MRSA

Methicillin-resistant Staphylococcus aureus.

16
New cards

ESBL

Extended-spectrum beta-lactamase.

17
New cards

CRE / CPE

Carbapenem-resistant Enterobacterales / Carbapenemase-producing Enterobacterales.

18
New cards

ASTAG High Rating Antibiotics

Antibacterial classes of high importance to human health, including 3rd generation cephalosporins, fluoroquinolones, carbapenems, and glycopeptides.

19
New cards

ASTAG Low Rating Antibiotics

Antibacterial classes including narrow spectrum penicillins (e.g., Procaine Penicillin G), tetracyclines, and macrolides.

20
New cards

Clinical Endpoint

A defined time to stop therapy, such as 24 hours after a patient starts eating or drinking voluntarily, to minimize the course duration.

21
New cards

Antimicrobial Stewardship "Get in, hit hard, get out"

A strategy involving not delaying treatment, giving appropriate high doses (dose-dependent) or frequency (time-dependent), and minimizing course duration.